Latest Insider Transactions at Akero Therapeutics, Inc. (AKRO)
This section provides a real-time view of insider transactions for Akero Therapeutics, Inc. (AKRO). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Akero Therapeutics, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Akero Therapeutics, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Oct 15
2021
|
Catriona Yale Chief Development Officer |
SELL
Open market or private sale
|
Direct |
12,500
-4.69%
|
$262,500
$21.96 P/Share
|
|
Oct 04
2021
|
Andrew Cheng President and CEO |
SELL
Open market or private sale
|
Direct |
17,500
-5.67%
|
$367,500
$21.54 P/Share
|
|
Oct 01
2021
|
William Richard White Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
6,500
-66.48%
|
$143,000
$22.06 P/Share
|
|
Oct 01
2021
|
William Richard White Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,500
+39.93%
|
$45,500
$7.01 P/Share
|
|
Sep 15
2021
|
Catriona Yale Chief Development Officer |
SELL
Open market or private sale
|
Direct |
12,500
-4.34%
|
$300,000
$24.94 P/Share
|
|
Sep 02
2021
|
Andrew Cheng President and CEO |
SELL
Open market or private sale
|
Direct |
17,500
-5.37%
|
$402,500
$23.89 P/Share
|
|
Sep 01
2021
|
William Richard White Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
8,559
-72.31%
|
$205,416
$24.0 P/Share
|
|
Sep 01
2021
|
William Richard White Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
8,559
+41.97%
|
$59,913
$7.01 P/Share
|
|
Sep 01
2021
|
Jonathan Young Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
12,500
-7.23%
|
$300,000
$24.04 P/Share
|
|
Aug 16
2021
|
Catriona Yale Chief Development Officer |
SELL
Open market or private sale
|
Direct |
10,000
-6.41%
|
$180,000
$18.79 P/Share
|
|
Aug 03
2021
|
Andrew Cheng President and CEO |
SELL
Open market or private sale
|
Direct |
17,500
-2.55%
|
$367,500
$21.15 P/Share
|
|
Aug 02
2021
|
William Richard White Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
4,441
-57.54%
|
$97,702
$22.03 P/Share
|
|
Aug 02
2021
|
William Richard White Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,441
+36.52%
|
$31,087
$7.01 P/Share
|
|
Jul 15
2021
|
Jonathan Young Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
9,000
+4.94%
|
$0
$0.62 P/Share
|
|
Jul 15
2021
|
Catriona Yale Chief Development Officer |
SELL
Open market or private sale
|
Direct |
10,000
-6.03%
|
$200,000
$20.9 P/Share
|
|
Jul 06
2021
|
William Richard White Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
6,500
-66.48%
|
$156,000
$24.52 P/Share
|
|
Jul 06
2021
|
William Richard White Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,500
+39.93%
|
$45,500
$7.01 P/Share
|
|
Jul 02
2021
|
Andrew Cheng President and CEO |
SELL
Open market or private sale
|
Direct |
17,500
-4.86%
|
$420,000
$24.78 P/Share
|
|
Jun 30
2021
|
Timothy Rolph Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,007
+0.41%
|
$21,147
$21.09 P/Share
|
|
Jun 28
2021
|
Apple Tree Partners Iv, L.P. > 10% Shareholder |
SELL
Other acquisition or disposition
|
Direct |
5,830,203
-100.0%
|
-
|
|
Jun 01
2021
|
Kevin Bitterman Director |
SELL
Open market or private sale
|
Indirect |
17,489
-100.0%
|
$454,714
$26.28 P/Share
|
|
Jun 01
2021
|
Jonathan Young Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
3,055
-1.83%
|
$79,430
$26.24 P/Share
|
|
May 03
2021
|
William Richard White Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
4,200
-64.92%
|
$126,000
$30.56 P/Share
|
|
May 03
2021
|
William Richard White Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,200
+39.36%
|
$29,400
$7.01 P/Share
|
|
May 03
2021
|
Jonathan Young Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
3,055
-1.8%
|
$91,650
$30.56 P/Share
|
|
Apr 01
2021
|
William Richard White Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
50,000
-63.53%
|
$1,400,000
$28.96 P/Share
|
|
Apr 01
2021
|
William Richard White Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
50,000
+48.89%
|
$350,000
$7.01 P/Share
|
|
Apr 01
2021
|
Jonathan Young Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
3,055
-1.76%
|
$85,540
$28.75 P/Share
|
|
Mar 01
2021
|
Jonathan Young Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
3,055
-0.87%
|
$91,650
$30.8 P/Share
|
|
Feb 01
2021
|
Jonathan Young Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
3,055
-0.85%
|
$88,595
$29.56 P/Share
|
|
Jan 10
2021
|
Andrew Cheng President and CEO |
SELL
Open market or private sale
|
Direct |
10,000
-3.24%
|
$190,000
$19.55 P/Share
|
|
Jan 08
2021
|
Jonathan Young Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
10,000
-5.28%
|
$280,000
$28.12 P/Share
|
|
Jan 07
2021
|
Jonathan Young Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,500
+3.81%
|
$0
$0.62 P/Share
|
|
Jan 07
2021
|
Andrew Cheng President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+5.22%
|
$0
$0.62 P/Share
|
|
Jan 04
2021
|
Jonathan Young Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
3,060
-0.83%
|
$76,500
$25.64 P/Share
|
|
Dec 31
2020
|
Andrew Cheng President and CEO |
SELL
Bona fide gift
|
Direct |
3,000
-0.83%
|
-
|
|
Dec 28
2020
|
Andrew Cheng President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
7,480
+2.13%
|
$0
$0.62 P/Share
|
|
Dec 21
2020
|
Andrew Cheng President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
10,500
+3.03%
|
$0
$0.62 P/Share
|
|
Dec 15
2020
|
Andrew Cheng President and CEO |
SELL
Bona fide gift
|
Direct |
2,500
-0.76%
|
-
|
|
Dec 11
2020
|
Andrew Cheng President and CEO |
SELL
Bona fide gift
|
Direct |
50
-0.02%
|
-
|
|
Oct 09
2020
|
Kevin Bitterman Director |
SELL
Open market or private sale
|
Indirect |
13,000
-52.46%
|
$364,000
$28.93 P/Share
|
|
Jun 30
2020
|
Andrew Cheng President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
1,245
+0.38%
|
$21,165
$17.07 P/Share
|
|
Jun 30
2020
|
Timothy Rolph Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,245
+0.51%
|
$21,165
$17.07 P/Share
|
|
Jun 30
2020
|
Catriona Yale Chief Development Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,245
+0.75%
|
$21,165
$17.07 P/Share
|
|
Jun 30
2020
|
William Richard White Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,245
+35.42%
|
$21,165
$17.07 P/Share
|
|
Jun 30
2020
|
Jonathan Young Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,245
+0.67%
|
$21,165
$17.07 P/Share
|
|
Jun 24
2019
|
Redmile Group, LLC > 10% Shareholder |
BUY
Conversion of derivative security
|
Indirect |
743,802
+50.0%
|
-
|